Christy M. Hebner

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen et al. · Nature · 2021 · 1.2K citations · Full text

Vaccination, Neutralizing Antibodies, Vaccine Target +6

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu et al. · Nature · 2021 · 563 citations · Full text

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

Andrea L. Cathcart, Colin Havenar‐Daughton, Florian A. Lempp et al. · 2021 · 250 citations · Full text

Viral Pathogenesis, Immunology, Immunodominance +17

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin et al. · Clinical Infectious Diseases · 2014 · 213 citations · Full text

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen et al. · Nature · 2021 · 213 citations · Full text

Vaccination, Neutralizing Antibodies, Vaccine Target +6